Skip to content

A Study on the Evaluation of Epilepsy Treatment with EEG

A Study on the Evaluation of Epilepsy Treatment with EEG - A Study on the Evaluation of Epilepsy Treatment with EEG

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000047427
Enrollment
600
Registered
2022-04-08
Start date
2020-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Interventions

None listed

Sponsors

Japan Agency for Medical Research and Development
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: In the case of pediatric epilepsy, epilepsy patients 15 years of age or younger who are admitted to the Osaka University Epilepsy Center or Osaka Women and Children Hospital and who can be followed for one year after the start of treatment. Adult epilepsy patients must be at least 16 years old and attending the Osaka University Hospital or Suita City Hospital, and must be able to be followed for one year after the start of treatment. In both cases, any seizure type is acceptable, and only those who have given written consent will be eligible.

Exclusion criteria

Exclusion criteria: Those deemed ineligible by the investigator and those whose seizure frequency and type are unknown.

Design outcomes

Primary

MeasureTime frame
seizure frequency (3 months and 12 months after the start of treatment)

Countries

Japan

Contacts

Public ContactTakufumi Yanagisawa

Osaka University Institute for Advanced Co-creation Studies Department of Neurosurgery

tyanagisawa@nsrug.med.osaka-u.ac.jp06-6879-5111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026